Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter

09 Aug 2024

Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter

Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales declined 73.56% to Rs 2.44 crore in the quarter ended June 2024 as against Rs 9.23 crore during the previous quarter ended June 2023.

ParticularsQuarter Ended
Jun. 2024Jun. 2023% Var.
Sales2.449.23 -74
OPM %14.756.50 -
PBDT0.270.49 -45
PBT0.270.49 -45
NP0.270.49 -45
Explore our products
₹0 Brokerage *
*By signing up you agree to our Terms and Conditions

Top Blogs

blog-article-image-one

Share Market

How to Invest in Gold ETF?

6 mins read . Nov 27, 2024

blog-article-image-one

Share Market

blog-article-image-one

Economy

Consolidated Fund of India - Explained

6 mins read . Nov 26, 2024

future contract
Explore our products
₹0 Brokerage *
Open Demat Account